Guidance. Clarity. Direction.

Carter DeLuca Farrell & Schmidt LLP, a leader in intellectual property law, provides cost-effective services to clients from around the world, protecting innovations in a wide range of technologies.

Throughout the phases of product or brand development, we form a critical part of our clients’ development teams to provide preparation, prosecution and clearance services to maximize protection while navigating through freedom-to-operate challenges. We also provide extensive IP due diligence services and IP asset assimilation to help our clients achieve their business objectives.

Search Attorneys

Events

Jan
22 – 22
2019
January New York HCD – Immuno-Oncology – Today and Tomorrow Attending Sponsoring
On Tuesday, January 22nd, New York Healthcare Drinks is hosting an after-work event focused on Immuno-Oncology. The event is co-sponsored by Carter, DeLuca, Farrell...
Jan
23 – 23
2019
SoPE NYC: Intellectual Property Law & Tax Credits for Life Science Companies Attending
Carter DeLuca Partner George Likourezos will appear on a panel hosted by Society of Physician Entrepreneurs to discuss Intellectual Property Law & Tax Credits for...

CAFC Update

AC TECHNOLOGIES S.A. v. AMAZON.COM, INC January 14, 2019

Amazon petitioned for inter partes review of (IPR) of AC Technologies S.A.’s U.S. Patent No. 7,904,680 (relating generally to data access and management), presenting three grounds. At institution, the Patent Trial and Appeal Board instituted review based on two of the three grounds. The Board issued a final written decision ruling certain claims of the ‘680 Patent unpatentable. On reconsideration, the Board invalidated...

AMERIGEN PHARMACEUTICALS v. UCB PHARMA GMBH January 11, 2019

Amerigen appeals from the decision of the PTAB in an inter partes review holding that certain claims of U.S. Patent No. 6,858,650 are not unpatentable as obvious. The ‘650 Patent covers certain chemical derivatives of 3,3-diphenylpropylamines, including a compound called fesoterodine, an antimuscarinic drug marketed as Toviaz® to treat urinary incontinence. Mylan petitioned for IPR of the ’650 patent, and the Board instituted...

Amerigen appeals from the decision of the PTAB in an inter partes review holding that certain claims of U.S. Patent No. 6,858,650 are not unpatentable as obvious. The ‘650...

WESTERNGECO L.L.C. v. ION GEOPHYSICAL CORP.

WesternGeco brought a patent infringement suit against ION Geophysical for infringement of four U.S. Patents relating to controlling the movement and positioning of long streamers towed by a ship during marine seismic surveys for discovering oil and gas deposits beneath the ocean floor. This case returns to the CAFC from the Supreme Court, which held that WesternGeco’s damages award for lost profits was...

WesternGeco brought a patent infringement suit against ION Geophysical for infringement of four U.S. Patents relating to controlling the movement and positioning of long streamers towed by a ship...